| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,930 | 6,966 | 7,138 | 7,778 | | Cost of Revenue | 1,595 | 1,441 | 1,938 | 2,175 | | | Gross Profit | 5,335 | 5,525 | 5,200 | 5,603 | | | Operating Expenses | | Research Development | 963 | 1,077 | 1,185 | 1,594 | | Selling General and Administrative | 4,966 | 5,378 | 5,552 | 6,175 | | Non Recurring | (75) | 75 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (519) | (1,005) | (1,537) | (2,166) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 104 | 153 | (70) | 175 | | Earnings Before Interest And Taxes | (415) | (853) | (1,607) | (1,991) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (415) | (853) | (1,607) | (1,991) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (415) | (853) | (1,607) | (1,991) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (415) | (853) | (1,607) | (1,991) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($415) | ($853) | ($1,607) | ($1,991) |
|
0.11% Nasdaq 
0.01%
Income Statement
